International Patent: M3C65 ANTIBODY AND DERIVATIVES THEREOF FOR TARGETING INFLAMMATION

GENEVA, July 31 -- ILTOO PHARMA filed a patent application (EP2026/051796) for “M3C65 ANTIBODY AND DERIVATIVES THEREOF FOR TARGETING INFLAMMATION”. With publication no. WO/2026/159300, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....